Company Joinn Laboratories(China)Co.,Ltd.

Equities

603127

CNE100002W27

Biotechnology & Medical Research

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Sales per region

Ratings for Joinn Laboratories(China)Co.,Ltd.

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Biotechnology & Medical Research

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-23 pm EDT			5-day change	1st Jan Change
17.05 ^CNY	-2.57%		+2.59%	-28.09%

Apr. 03	Tranche Update on Joinn Laboratories(China)Co.,Ltd.'s Equity Buyback Plan announced on April 3, 2024.	CI
Apr. 03	Joinn Laboratories(China)Co.,Ltd. announces an Equity Buyback for CNY 100 million worth of its shares.	CI

Joinn Laboratories China Co Ltd is a China-based company primarily engaged in the pharmacology and toxicology research of new drugs. Non-clinical research services include drug safety evaluation, pharmacokinetic research as well as pharmacological and pharmacodynamic research. Clinical trials and related services include clinical contract research organization services, phase I clinical research collaboration unit (CRU), and bioanalysis services. Experimental model business mainly includes rodents and non-human primates. The Company conducts its businesses both in the domestic market and overseas markets.

Number of employees: 2,510

CNY in Million	2022	Weight	2023	Weight	Delta
Drug Non-clinical Research Services 97.3 %	2,215	97.7 %	2,313	97.3 %	+4.41%
Inter-segment Elimination -6.2 %	-436	-19.2 %	-147	-6.2 %	-66.33%
Experimental Model Supply 6.2 %	439	19.3 %	146	6.2 %	-66.63%
Clinical Services and Others 2.7 %	50	2.2 %	64	2.7 %	+28.41%

CNY in Million	2022	Weight	2023	Weight	Delta
China 75.6 %	1,885	83.1 %	1,798	75.6 %	-4.64%
Overseas 24.4 %	383	16.9 %	579	24.4 %	+51.20%

Managers	Title	Age	Since
Da Peng Gao CEO	Chief Executive Officer	42	12-10-31
Ai Shui Yu DFI	Director of Finance/CFO	48	19-06-30
Ye Li CHM	Chairman	42	06-12-31
Ying Jun He BRD	Director/Board Member	49	21-07-31
Da Lin Yao BRD	Director/Board Member	75	12-01-31
Li Li Yin BRD	Director/Board Member	44	05-12-31
Yun Xia Sun BRD	Director/Board Member	56	99-09-30
Cong Lin Zuo BRD	Director/Board Member	60	96-11-30
Feng Song Jia IRC	Investor Relations Contact	-	-
Ka Lun Cheung SEC	Corporate Secretary	-	22-04-27

Members of the board	Title	Age	Since
Yu Xia Feng FOU	Founder	60	95-08-10
Cong Lin Zuo BRD	Director/Board Member	60	96-11-30
Yun Xia Sun BRD	Director/Board Member	56	99-09-30
Da Peng Gao CEO	Chief Executive Officer	42	12-10-31
Ye Li CHM	Chairman	42	06-12-31
Li Li Yin BRD	Director/Board Member	44	05-12-31
Hui Ye Sun BRD	Director/Board Member	56	05-12-31
Da Lin Yao BRD	Director/Board Member	75	12-01-31
Ying Jun He BRD	Director/Board Member	49	21-07-31
Fan Zhang BRD	Director/Board Member	45	20-09-14

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	118,995,206	110,449,726 ( 92.82 %)	0	58.77 %
Stock B	1	637,150,739	333,961,028 ( 52.41 %)	6,257,246 ( 0.9821 %)

Name	Equities	%	Valuation
Gu Family 22.82 %	27,155,002	22.82 %	32 M ¥
Futu Trustee Ltd. 7.181 %	8,545,480	7.181 %	10 M ¥
APG Asset Management NV 4.921 %	5,856,144	4.921 %	7 M ¥
Brown Brothers Harriman & Co. (Investment Management) 4.819 %	5,734,868	4.819 %	7 M ¥
UBS SDIC Fund Management Co., Ltd. 3.430 %	4,081,784	3.430 %	5 M ¥
FIL Investment Management (Singapore) Ltd. 3.082 %	3,666,840	3.082 %	4 M ¥
FIL Investment Management (Hong Kong) Ltd. 2.821 %	3,356,490	2.821 %	4 M ¥
Abrdn Investment Management Ltd. 2.778 %	3,305,636	2.778 %	4 M ¥
Abrdn Asia Ltd. 1.494 %	1,777,928	1.494 %	2 M ¥
BlackRock Advisors (UK) Ltd. 1.270 %	1,511,160	1.270 %	2 M ¥

Name	Equities	%	Valuation
Yu Xia Feng 26.51 %	167,160,633	26.51 %	418 M ¥
Zhi Wen Zhou 11.85 %	74,725,981	11.85 %	187 M ¥
Zhong Ou Asset Management Co., Ltd 4.356 %	27,465,890	4.356 %	69 M ¥
Xiao Lei Gu 3.397 %	21,420,504	3.397 %	54 M ¥
Harvest Fund Management Co., Ltd. 2.588 %	16,319,096	2.588 %	41 M ¥
Cong Lin Zuo 2.236 %	14,098,317	2.236 %	35 M ¥
Mei Fang Gu 1.637 %	10,322,035	1.637 %	26 M ¥
Hwabao WP Fund Management Co., Ltd. 1.612 %	10,161,631	1.612 %	25 M ¥
China Merchants Fund Management Co., Ltd. 1.190 %	7,503,376	1.190 %	19 M ¥
GF Fund Management Co., Ltd. 0.4742 %	2,990,048	0.4742 %	7 M ¥

Name	Equities	%	Valuation
JOINN LABORATORIES(CHINA)CO.,LTD. 0.01%	46,500	0.01%	116,323 $

JOINN Laboratories (China) Co., Ltd.

5-A Rongjing East Street Beijing Economic-Tech & Dev Zone

100176, Beijing

http://www.joinn-lab.com

address Joinn Laboratories(China)Co.,Ltd.(603127)

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

17.05 CNY

Average target price

19.29 CNY

Spread / Average Target

+13.15%

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
JOINN LABORATORIES(CHINA)CO.,LTD.	-28.09%	1.67B
IQVIA HOLDINGS INC.	+4.09%	43.43B
LONZA GROUP AG	+47.81%	41.69B
MODERNA, INC.	+9.45%	41.31B
CELLTRION, INC.	-10.92%	27.14B
ICON PUBLIC LIMITED COMPANY	+9.32%	25.28B
ALNYLAM PHARMACEUTICALS, INC.	-24.87%	18.47B
MEDPACE HOLDINGS, INC.	+29.70%	12.59B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	+1.28%	12.33B
UNITED THERAPEUTICS CORPORATION	+7.78%	11.03B

Other Biotechnology & Medical Research